Back to search

Article

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

2024-11-01

Abstract excerpt

<title>Abstract</title> <p>SMOC1 has emerged as one of the most significant and consistent new biomarkers of early Alzheimer’s disease (AD). Recent studies show that SMOC1 is one of the earliest changing proteins in AD, with levels in the cerebrospinal fluid increasing many years before symptom onset. Despite this clear association with disease, little is known about the role of SMOC1 in AD or its function in the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b042442-a727-514f-978d-301faec804c2
DOI
10.21203/rs.3.rs-5229472/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregationDOI 10.21203/rs.3.rs-5229472/v1
Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signatureSemantic proximity
CSF 14-3-3ζ is associated with tau pathology and elevated across the Alzheimer’s disease continuumSemantic proximity
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progressionSemantic proximity
Lecanemab binds to transgenic mouse model-derived amyloid-β fibril structures resembling Alzheimer’s disease type-I, type-II and Arctic foldsSemantic proximity
The MET growth signaling complex drives Alzheimer’s Disease-associated brain pathology in aged Shugoshin 1 mouse cohesinopathy modelSemantic proximity
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.Semantic proximity
Proteomic Changes in the Human Cerebrovasculature in Alzheimer’s Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal FluidSemantic proximity
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeSemantic proximity
Select a neighboring publication to make it the new centre.